Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus Erythematosus. [PDF]
, 2020 ObjectiveTo evaluate the frequency of cell-bound complement activation products (CB-CAPs) as a marker of complement activation in patients with suspected systemic lupus erythematosus (SLE) and the usefulness of this biomarker as a predictor of the ...
Alexander, Roberta Vezza +12 more
core +2 more sources
Ocular changes due to the treatment of juvenile systemic lupus erythematosus [PDF]
, 2011 OBJECTIVE: To assess retrospectively the ocular changes in children and adolescents with juvenile systemic lupus erythematosus (JSLE) in a tertiary pediatric rheumatology service.
Finamor, Luciana Peixoto dos Santos +6 more
core +3 more sources
The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus [PDF]
, 2010 Systemic lupus erythematosus is a prototypical autoimmune disease characterized by the deregulation of T and B cells, tissue infiltration by mononuclear cells, tissue damage and the production of autoantibodies.
KISS, Maria Helena Bittencourt +1 more
core +5 more sources
Rhupus arthropathy as the presenting manifestation in Juvenile SLE: a case report [PDF]
, 2007 An 8.5-year-old girl was referred with swelling of both knees lasting for two years. ANA was found as negative. She was diagnosed as oligoarticular JIA. After two years of follow-up, thrombocytopenia was detected during routine screening.
Ayse Arlı, Erbil Unsal, Hakkı Akman
core +3 more sources
Vitamin D supplementation in the pediatric rheumatology clinic. [PDF]
, 2011 Vitamin D is capturing the attention of healthy and chronically ill populations for its potential skeletal and nonskeletal benefits. New information suggesting a role in immune modulation has led to a surge of interest among rheumatologists. Although the
Burnham, Jon M, von Scheven, Emily
core +3 more sources
Revista Brasileira de Reumatologia, 2016 Objective To determine whether there is an association between the profile of cognitive dysfunction and academic outcomes in patients with juvenile systemic lupus erythematosus (JSLE).
Renan Bazuco Frittoli +5 more
doaj +1 more source
A discrete cluster of urinary biomarkers discriminates between active systemic lupus erythematosus patients with and without glomerulonephritis. [PDF]
, 2016 BackgroundManagement of lupus nephritis (LN) would be greatly aided by the discovery of biomarkers that accurately reflect changes in disease activity.
Avila-Casado, Carmen +10 more
core +3 more sources
Pediatric Rheumatology Online Journal, 2018 Tocilizumab, an anti-interleukin-6 (IL-6) agent, is indicated as a treatment for several autoimmune or inflammatory diseases, including rheumatoid arthritis and juvenile idiopathic arthritis (JIA). IL-6 plays roles in both immune system dysregulation and
Ju-Yang Jung +3 more
doaj +1 more source
Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus. [PDF]
, 2016 The aim of this study was to describe the abnormalities identified with conventional MRI in children with neuropsychiatric systemic lupus erythematosus (NPSLE).
Al-Obaidi, M +8 more
core +1 more source
FRI0627-HPR COGNITIVE DISORDERS IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH JUVENILE-ONSET: ONE SINGLE CENTER EXPERIENCE [PDF]
Annals of the Rheumatic Diseases, 2020 Background: Juvenile-onset SLE (jSLE) is a more aggressive disease than in adults due to several reasons including cognitive dysfunction, significantly affected the compliance and social rehabilitation of patients (pts). Objectives: To analyze the cognitive, emotional and communicative status of pts with jSLE.
M. Kaleda, N. Stepanenko, I. Nikishina
openaire +1 more source